Why These 5 Stocks Are On the Move on Friday

4. Moderna, Inc. (NASDAQ: MRNA) is off around 6% due to the debate over the potential need for booster shots. Portfolio manager at Gabelli Funds Jeff Jonas said, “When (the stocks) ran up, I think it was expecting a booster shot to be given to everyone. Now I think it’s maybe a little less certain that that extra demand is going to be there.” Whether booster shots will be needed for everyone or just some people is still not clear. The change in demand could affect Moderna, Inc. (NASDAQ: MRNA)’s future results.

For the June 30, 2021 filing period, our data indicates that Philippe Laffont’s Coatue Management owned more than 6.14 million shares of Moderna, Inc. (NASDAQ: MRNA), up 389% from the prior period.